Business Description
Sofgen Pharma SA
NAICS : 325411
SIC : 2833
ISIN : LU2376511205
Description
Sofgen Pharma SA ia an integrated healthcare and pharmaceutical company that develops and manufactures pharmaceutical and nutraceutical solutions. The group has a direct presence in the United States, Brazil, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Peru, and Bolivia.
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.21 | |||||
9-Day RSI | 39.98 | |||||
14-Day RSI | 37.61 | |||||
3-1 Month Momentum % | -98.8 | |||||
6-1 Month Momentum % | -98.76 | |||||
12-1 Month Momentum % | -99.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-EBIT | 8.32 | |||||
EV-to-Forward-Revenue | 1.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PROCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sofgen Pharma SA Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 423.748 | ||
| EPS (TTM) ($) | 0.41 | ||
| Beta | -12.2118 | ||
| 3-Year Sharpe Ratio | 0.55 | ||
| 3-Year Sortino Ratio | 4.45 | ||
| Volatility % | 1439.45 | ||
| 14-Day RSI | 37.61 | ||
| 14-Day ATR ($) | 0.001757 | ||
| 20-Day SMA ($) | 0.001495 | ||
| 12-1 Month Momentum % | -99.97 | ||
| 52-Week Range ($) | 0.0001 - 1.4 | ||
| Shares Outstanding (Mil) | 2,327.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sofgen Pharma SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sofgen Pharma SA Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-10-12 | In 34 days | ||
| General meeting for 2025 | 2026-09-08 | -- | ||
| Second quarter earnings results for 2026 | 2026-09-08 | -- | ||
| Annual report for 2024 | 2026-03-16 | 0.02 (+0.00%) | ||
| General meeting for 2025 | 2025-12-16 19:00 | 0.03 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 0.03 (+0.00%) | ||
| Annual report for 2023 | 2025-09-03 | 1.11 (+0.00%) | ||
| Second quarter earnings conference call for 2025 | 2025-08-15 | 1.10 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-15 | 1.10 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 1.45 (+0.00%) |
Show
Entries
Sofgen Pharma SA Frequently Asked Questions
What is Sofgen Pharma SA(PROCF)'s stock price today?
The current price of PROCF is $0.00. The 52 week high of PROCF is $1.40 and 52 week low is $0.00.
When is next earnings date of Sofgen Pharma SA(PROCF)?
The next earnings date of Sofgen Pharma SA(PROCF) is 2026-09-08 Est..
Does Sofgen Pharma SA(PROCF) pay dividends? If so, how much?
Sofgen Pharma SA(PROCF) does not pay dividend.
Press Release
Articles on Sofgen Pharma SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers